Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M411320200 on March 30, 2005

J. Biol. Chem., Vol. 280, Issue 22, 20932-20936, June 3, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/22/20932    most recent
M411320200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whittaker, J.
Right arrow Articles by Whittaker, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whittaker, J.
Right arrow Articles by Whittaker, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Characterization of the Functional Insulin Binding Epitopes of the Full-length Insulin Receptor*

Jonathan Whittaker{ddagger}§ and Linda Whittaker{ddagger}

From the Departments of {ddagger}Nutrition and §Biochemistry, Case Western Reserve University, Cleveland, Ohio 44106-4906

Mutational analyses of the secreted recombinant insulin receptor extracellular domain have identified a ligand binding site composed of residues located in the L1 domain (amino acids 1–470) and at the C terminus of the {alpha} subunit (amino acids 705–715). To evaluate the physiological significance of this ligand binding site, we have transiently expressed cDNAs encoding full-length receptors with alanine mutations of the residues forming the functional epitopes of this binding site and determined their insulin binding properties. Insulin bound to wild-type receptors with complex kinetics, which were fitted to a two-component sequential model; the Kd of the high affinity component was 0.03 nM and that of the low affinity component was 0.4 nM. Mutations of Arg14, Phe64, Phe705, Glu706, Tyr708, Asn711, and Val715 inactivated the receptor. Alanine mutation of Asn15 resulted in a 20-fold decrease in affinity, whereas mutations of Asp12, Gln34, Leu36, Leu37, Leu87, Phe89, Tyr91, Lys121, Leu709, and Phe714 all resulted in 4–10-fold decreases. When the effects of the mutations were compared with those of the same mutations of the secreted recombinant receptor, significant differences were observed for Asn15, Leu37, Asp707, Leu709, Tyr708, Asn711, Phe714, and Val715, suggesting that the molecular basis for the interaction of each form of the receptor with insulin differs. We also examined the effects of alanine mutations of Asn15, Gln34, and Phe89 on insulin-induced receptor autophosphorylation. They had no effect on the maximal response to insulin but produced an increase in the EC50 commensurate with their effect on the affinity of the receptor for insulin.


Received for publication, October 4, 2004 , and in revised form, March 11, 2005.

* This work was supported by National Institutes of Health Grant 5 R01 DK065890 and Juvenile Diabetes Research Foundation International Grant 1-2000-198 (to J. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Nutrition, Case Western Reserve University, Dental Bldg., 2123 Abington Rd., Rm. 201, Cleveland, OH 44106-4906. Tel.: 216-368-6625; Fax: 216-368-6644; E-mail: Jonathan.Whittaker{at}case.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. L. Alvino, K. A. McNeil, S. C. Ong, C. Delaine, G. W. Booker, J. C. Wallace, J. Whittaker, and B. E. Forbes
A Novel Approach to Identify Two Distinct Receptor Binding Surfaces of Insulin-like Growth Factor II
J. Biol. Chem., March 20, 2009; 284(12): 7656 - 7664.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z.-l. Wan, K. Huang, S.-Q. Hu, J. Whittaker, and M. A. Weiss
The Structure of a Mutant Insulin Uncouples Receptor Binding from Protein Allostery: AN ELECTROSTATIC BLOCK TO THE TR TRANSITION
J. Biol. Chem., July 25, 2008; 283(30): 21198 - 21210.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
D. S. Patel, A. Garza-Garcia, M. Nanji, J. J. McElwee, D. Ackerman, P. C. Driscoll, and D. Gems
Clustering of Genetically Defined Allele Classes in the Caenorhabditis elegans DAF-2 Insulin/IGF-1 Receptor
Genetics, February 1, 2008; 178(2): 931 - 946.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Huang, S. J. Chan, Q.-x. Hua, Y.-C. Chu, R.-y. Wang, B. Klaproth, W. Jia, J. Whittaker, P. De Meyts, S. H. Nakagawa, et al.
The A-chain of Insulin Contacts the Insert Domain of the Insulin Receptor: PHOTO-CROSS-LINKING AND MUTAGENESIS OF A DIABETES-RELATED CREVICE
J. Biol. Chem., November 30, 2007; 282(48): 35337 - 35349.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Chan, S. Nakagawa, and D. F. Steiner
Complementation Analysis Demonstrates That Insulin Cross-links Both {alpha} Subunits in a Truncated Insulin Receptor Dimer
J. Biol. Chem., May 4, 2007; 282(18): 13754 - 13758.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. N. Johnson-Farley, T. Travkina, and D. S. Cowen
Cumulative Activation of Akt and Consequent Inhibition of Glycogen Synthase Kinase-3 by Brain-Derived Neurotrophic Factor and Insulin-Like Growth Factor-1 in Cultured Hippocampal Neurons
J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1062 - 1069.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement